Journal of the American Chemical Society
Page 4 of 5
trast, upon the injection Tiron to the LPS-pretreated mouse,
tions. These interesting results and limited tissue penetration
1
2
3
4
5
6
7
8
CL intensity weakened distinctly. Meanwhile, Figure 4a IV
demonstrated that there was no emission in the group with
only saline injection, indicating no background fluorescence.
Apparently, owing to no interference from biological auto-
fluorescence, effective CRET and interior hydrophobic condi-
tion of this nanoprobe, imaging quality and sensitivity were
significantly upgraded. Moreover, Figure S9 demonstrated
enough long luminescence time was benefit to conveniently
monitor O2•−. Altogether, we conclude that PCLA-O2•− allows
for in situ imaging of the O2•− in vivo by means of CL.
capability of 560 nm prompt us to develop the new near-
infrared probe for deep tissue imaging and clinical applica-
tions in superoxide anion related biological and medical re-
search. And also, we can investigate the similar CRET plat-
forms to visualize other active molecules in vivo.
ASSOCIATED CONTENT
Supporting Information
9
Synthesis, characterization, and experimental details. This
material is available free of charge via the Internet at http://
pubs.acs.org.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
AUTHOR INFORMATION
Corresponding Author
Notes
The authors declare no competing financial interests.
ACKNOWLEDGMENT
Figure 5. a) Representative images (pseudocolor) of mice in
vivo tumor (I), tumor+Tiron (II) and normal (III) tissues
followed by PCLA-O2•− (n = 3). Images (λem=570±10 nm) were
acquired using an IVIS Lumina II at 30 s after PCLA-O2 ad-
ministration. b) Quantitative CL intensities of (I)-(III).
This work was supported by 973 Program (2013CB933800)
and National Natural Science Foundation of China (21390411
, 21535004,21227005, 21475079, and 21305080).
•−
REFERENCES
•−
To further assess the practicability of PCLA-O2 to spy on
•−
(1) Fruehauf, J.; Meyskens, F. Clin. Cancer Res. 2007, 13, 789-794.
(2) Dröge, W. Physiol. Rev. 2002, 82, 47-95.
(3) Gorrini, C.; Harris, I. S.; Mak, T. W. Nat. Rev. Drug Discov.
2013, 12, 931-947.
(4) Dickinson, B. C.; Chang, C. J. Nat. Chem. Biol. 2011, 7, 504−511.
(5) Teranishi, K. Bioorg. Chem. 2007, 35, 82-111.
(6) Sekiya, M.; Umezawa, K.; Sato, A.; Citterio, D.; Suzuki, K.
Chem. Commun. 2009, 3047-3049.
(7) Teranishi, K.; Nishiguchi, T. Anal. Biochem. 2004, 325, 185-195.
(8) Shuhendler, A. J.; Pu, K.; Cui, L.; Uetrecht, J. P.; Rao, J. H. Nat.
Biotechnol. 2014, 32, 373-380.
(9) Xiong, L. Q.; Shuhendler, A. J.; Rao, J. H. Nat. Commun. 2012, 3,
1193-1200.
(10) Roda, A.; Guardigli, M. Anal. Bioanal. Chem. 2012, 402, 69-76.
(11) Li, K.; Liu, B. Chem. Soc. Rev. 2014, 43, 6570−6597.
(12) Feng, L.; Zhu, C.; Yuan, H.; Liu, L.; Lv, F.; Wang, S. Chem. Soc.
Rev. 2013, 42, 6620-6633.
(13) Swager, T. M. Acc. Chem. Res. 1998, 31, 201-207.
(14) Liu, J.; Lam, J. W. Y.; Tang, B. Z. Chem. Rev. 2009, 109, 5799-
5867.
(15) Wu, C.; Chiu, D. T. Angew. Chem., Int. Ed. 2013, 52, 3086-3109.
(16) Freeman, R.; Liu, X.; Willner, I. J. Am. Chem. Soc. 2011, 133,
11597-11604.
(17) Liu, X.; Freeman, R.; Golub, E.; Willner, I. ACS Nano. 2011, 5,
7648−7655.
(18) Wu, I. C.; Yu, J.; Ye, F.; Rong, Y.; Gallina, M. E.; Fujimoto, B.
S.; Zhang, Y.; Chan, Y. H.; Sun, W.; Zhou, X. H.; Wu, C.; Chiu, D. T. J.
Am. Chem. Soc. 2015, 137, 173-178.
(19) Liu, B.; Bazan, G. C. Nat. Protoc. 2006, 1, 1698-1702.
(20) Maeda, H.; Yamamoto, K.; Nomura, Y.; Kohno, I.; Hafsi, L.;
Ueda, N. Y., S.; Fukuda, M.; Fukuyasu, Y.; Yamauchi, Y.; Itoh, N. J.
Am. Chem. Soc. 2005, 127, 68-69.
(21) Zorov, D. B.; Filburn, C. R.;, Klotz, L. O.; Zweier, J. L.; Sollott,
S. J. J. Exp. Med. 2000, 192, 1001-1014.
intrinsic O2 in the absence of stimulation, we examined
•−
whether it could distinguish the difference on O2 concen-
trations between normal and tumor tissues in mice. A mouse
mammary carcinoma model was constructed by injecting 4T1
cells in forelimb armpit. After 10 days, a tumor mass was ob-
tained. Then, PCLA-O2•− (0.068 mg) was injected in tumor (I),
tumor+Tiron (II) and normal (III) tissues of the mice, respec-
•−
tively. Subsequently, we found PCLA-O2 displayed much
stronger CL in tumor tissue than that of in normal tissue
(Figure 5a). The CL intensity was 3.0-times higher than the
normal tissue (Figure 5b), indicating noticeably higher level
•−
of O2 in the tumor tissue. Meanwhile, weak CL signal in
tumor tissue was observed after injection of Tiron. The re-
sults presented here validate for the first time visualization of
the O2•− native variance without stimulation in small animals.
In summary, we describe a supersensitive imaging nano-
•−
•−
probe PCLA-O2 for O2 based on CRET between imidaz-
opyrazinone and conjugated polymers. Without an external
excitation source, the attractive probe was applied in mice to
•−
selectively visualize O2 in normal/inflammation tissues.
•−
More importantly, as the most sensitive O2 probe to our
•−
knowledge, PCLA-O2 revealed native concentration differ-
•−
ences of O2 between normal and tumor tissues without
exogenous stimulation. The above breakthroughs achieved
are attributed to several remarkable advantages of the new
imaging probe: (1) elevated CRET efficiency by covalent link
between accepter and donor, (2) substantially extended lu-
minescence time due to effective CRET process, (3) signifi-
cantly enhanced CL intensity under interior hydrophobic
environment via polymer nanoparticle formation, (4) greatly
improved sensitivity and imaging resolution owing to longer
luminescence time and no background fluorescence interfer-
(22) Afonso, V.; Champy, R.; Mitrovic, D.; Collin, P.; Lomri, A.
Joint, bone, spine. 2007, 74, 324-329.
(23) Lee, D.; Khaja, S.; Velasquez-Castano, J. C.; Dasari, M.; Sun,
C.; Petros, J.; Taylor, W. R.; Murthy, N. Nat. Mater. 2007, 6, 765-769.
•−
ence without external light source. We deem that PCLA-O2
would serve as a powerful tool to differentiate normal tissues
•−
and pathological tissues via distinguishing O2 concentra-
ACS Paragon Plus Environment